|
|
Home > Healthcare > Biotechnology > Genetics & Genomics
Nucleic Acid Testing: A Vehicle for Advancing Personalized Medicine
|
| Published Date:
April 2009
Published By:
Decision Resources
Page Count:
29
Order Code:
R55-638
|
|
|
|
- Executive Summary
- Strategic Considerations
- Stakeholder Implications
- Introduction to NAT—A Central Technology
- Driving the Evolution to Personalized Medicine
- Affecting Drug Discovery and Approval
- Leading the Molecular Diagnostic Assay Technologies
- Scope of the Report
- The NAT Toolbox: Technologies for Now and the Future
- Therapeutic Focus of the NAT Market
- Blood Screening and Infectious Diseases
- Testing for Sexually Transmitted Infections
- Hospital-Acquired Infections Testing
- HIV Drug Resistance Testing
- Infectious Respiratory Diseases
- Oncology
- Hereditary Risk Assays
- Early Detection Assays
- Targeted Therapy Assays
- Assays for Cancer Prognosis
- Assays Guiding Treatment Options
- Company Leaders in NAT
- Future Trends
- Applications That Will Drive the NAT Market for the Foreseeable Future
- Leading Companies in NAT Will Drive Growth Through Acquisitions and Licensing
- NAT Assays Are High Value, but Tests Need to Demonstrate Cost-Effectiveness
- Sidebar
- Using Discovery Tools to Shape Future NAT Oncology Assays
- Tables
- 1. The Nucleic Acid Testing Toolbox
- 2. Validated Genomic Biomarkers for Select Approved Agents
- 3. Select Nucleic Acid Testing Leaders, by Market Segment
- 4. Select Acquisitions in NAT, November 2007-December 2008
- Appendix A. Select Licensing and Collaboration Activities in NAT, November 2007-December 2008
- Figures
- 1. NAT Alliances in 2008, by Therapeutic Area
- 2. Algorithm for the Diagnosis of Chronic Hepatitis C
- 3. Cancer Molecular Targets
|
Similar Products
• Biotechnology Sector
Published Nov 2009 by First Research, Inc.
• Dealmaking and Industry Outlook: Neurological Disease
Published Nov 2009 by Decision Resources
• Protein Kinase Therapeutics in Oncology - Where to Commercialize?
Published Oct 2009 by BioSeeker Group AB
• Plunkett's Health Care Technologies Overview 2010 (Summary)
Published Oct 2009 by Plunkett Research, Ltd.
• The Human Genome Sequencing Center at Baylor College of Medicine Relies on Quantum's StorNext Software for Data Management
Published Oct 2009 by IDC
• Three Alternative Scenarios Of The Future In Vitro Diagnostics Market 2009-2018
Published Oct 2009 by Venture Planning Group
• Preventive Healthcare Technologies, Products and Markets
Published Oct 2009 by BCC Research
• Transfection Life Science Dashboard™ Series 2
Published Oct 2009 by Percepta Associates, Inc.
• Genealogy Products and Services
Published Oct 2009 by Global Industry Analysts
• Advances in the Use of Biomarkers in Biochip and Microarray Testing: Innovative technologies, growth opportunities and the future market outlook
Published Oct 2009 by Business Insights
|
|
|
|
0 items
